HI
CATX icon

Harbour Investments’s Perspective Therapeutics CATX Stock Holding History

Harbour Investments’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-190
Closed -$2K – 3756
2021
Q2 		$2K Hold
190
– – ﹤0.01% 3348
2021
Q1 		$2K Buy
+190
New +$2.87K ﹤0.01% 3188

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HPWM
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harbour Investments's CATX Position: Q3 2021 in Review

Harbour Investments sold out of Perspective Therapeutics (CATX) in Q3 2021, closing a stake of 190 shares — an estimated $2K sold.

Harbour Investments first reported a position in CATX in Q1 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2021. 43 funds tracked by Wall St. Rank hold CATX as of Q3 2021.

  • Harbour Investments reported no remaining Perspective Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Harbour Investments sold 190 Perspective Therapeutics shares in Q3 2021, an estimated $2K.
  • Harbour Investments first reported a position in Perspective Therapeutics in Q1 2021 and held it in 2 quarters.
  • Harbour Investments's Perspective Therapeutics position peaked at $2K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2021.

Based on Harbour Investments's 13F filing for Q3 2021, filed 15 Nov 2021.